Suzhou Novoprotein Scientific Co (SHSE:688137) Long-Term Capital Lease Obligation : ¥62.3 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Suzhou Novoprotein Scientific Co Long-Term Capital Lease Obligation?

Suzhou Novoprotein Scientific Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥62.3 Mil.

Suzhou Novoprotein Scientific Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (¥60.7 Mil) to Dec. 2023 (¥59.4 Mil) but then increased from Dec. 2023 (¥59.4 Mil) to Mar. 2024 (¥62.3 Mil).

Suzhou Novoprotein Scientific Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥78.3 Mil) to Dec. 2022 (¥69.2 Mil) and declined from Dec. 2022 (¥69.2 Mil) to Dec. 2023 (¥59.4 Mil).

Suzhou Novoprotein Scientific Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Suzhou Novoprotein Scientific Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Novoprotein Scientific Co Long-Term Capital Lease Obligation Chart

Suzhou Novoprotein Scientific Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

11.16

78.34

69.20

59.44

Suzhou Novoprotein Scientific Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial											67.04	63.70	60.74	59.44	62.30

Suzhou Novoprotein Scientific Co (SHSE:688137) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Suzhou Novoprotein Scientific Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Suzhou Novoprotein Scientific Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Novoprotein Scientific Co (SHSE:688137) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Novoprotein Scientific Co Ltd (SHSE:688137) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299

Website

http://www.novoprotein.com.cn

Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes and reagents, Production and sales, and provide related technical services.

Suzhou Novoprotein Scientific Co (SHSE:688137) Headlines

No Headlines